1. Home
  2. NVX vs MSLE Comparison

NVX vs MSLE Comparison

Compare NVX & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NOVONIX Limited American Depository Shares

NVX

NOVONIX Limited American Depository Shares

HOLD

Current Price

$0.67

Market Cap

144.3M

Sector

Miscellaneous

ML Signal

HOLD

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$5.75

Market Cap

146.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NVX
MSLE
Founded
2012
N/A
Country
Australia
Canada
Employees
192
17
Industry
Industrial Machinery/Components
Sector
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
144.3M
146.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NVX
MSLE
Price
$0.67
$5.75
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
325.9K
27.5K
Earning Date
04-30-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3,904.19
N/A
Revenue Next Year
$91.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$5.50
52 Week High
$3.86
$13.39

Technical Indicators

Market Signals
Indicator
NVX
MSLE
Relative Strength Index (RSI) 51.10 37.65
Support Level $0.61 $5.56
Resistance Level $0.75 $8.59
Average True Range (ATR) 0.05 0.44
MACD 0.00 -0.09
Stochastic Oscillator 68.20 7.10

Price Performance

Historical Comparison
NVX
MSLE

About NVX NOVONIX Limited American Depository Shares

NOVONIX Ltd is a battery technology company developing and scaling materials and equipment critical to the lithium-ion battery supply chain. The company has three operating segments: Battery Materials: It develops and manufactures battery anode materials, ii) Battery Technology: It develops and manufactures battery cell testing equipment, performs consulting services and carries out research and development in battery development, and Graphite Exploration: It manages the maintenance and future development of Mount Dromedary natural graphite deposit. The majority of the company's revenue is derived from the Battery Technology segment. Geographically, the maximum revenue is derived from North America, followed by Asia, and Europe.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: